Nomogram Based on Inflammatory Biomarkers to Predict the Recurrence of Hepatocellular Carcinoma—A Multicentre Experience

References

• Villanueva A, Longo DL. Hepatocellular Carcinoma. N Engl J Med. 2019;380(15):1450–1462. doi:10.1056/NEJMra1713263
   PubMed Web of Science ®Google Scholar
• Choo SP, Tan WL, Goh BKP, Tai WM, Zhu AX. Comparison of hepatocellular carcinoma in Eastern versus Western populations. Cancer. 2016;122(22):3430–3446. doi:10.1002/cncr.30237
   PubMed Web of Science ®Google Scholar
• Benson AB, D’Angelica MI, Abbott DE, et al. Hepatobiliary cancers, version 2. 2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(5):541–565. doi:10.6004/jnccn.2021.0022
   PubMed Web of Science ®Google Scholar
• Zhou J, Sun H, Wang Z, et al. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 edition). Liver Cancer. 2020;9(6):682–720. doi:10.1159/000509424
   PubMed Web of Science ®Google Scholar
• Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358–380. doi:10.1002/hep.29086
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236. doi:10.1016/j.jhep.2018.03.019
   PubMed Web of Science ®Google Scholar
• Bruix J, Reig M, Sherman M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology. 2016;150(4):835–853. doi:10.1053/j.gastro.2015.12.041
   PubMed Web of Science ®Google Scholar
• Ikeda M, Kudo M, Aikata H, et al. Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a Phase III randomized trial. J Gastroenterol. 2018;53(2):281–290. doi:10.1007/s00535-017-1374-6
   PubMed Web of Science ®Google Scholar
• Ishizawa T, Hasegawa K, Aoki T, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology. 2008;134(7):1908–1916. doi:10.1053/j.gastro.2008.02.091
   PubMed Web of Science ®Google Scholar
• Li S, Mei J, Wang Q, et al. Postoperative adjuvant transarterial infusion chemotherapy with FOLFOX could improve outcomes of hepatocellular carcinoma patients with microvascular invasion: a preliminary report of a Phase III, randomized controlled clinical trial. Ann Surg Oncol. 2020;27(13):5183–5190. doi:10.1245/s10434-020-08601-8
   PubMed Web of Science ®Google Scholar
• Wei W, Jian PE, Li SH, et al. Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety. Cancer Commun. 2018;38(1):61. doi:10.1186/s40880-018-0331-y
   PubMed Web of Science ®Google Scholar
• Kamarajah SK, Frankel TL, Sonnenday C, Cho CS, Nathan H. Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): a Surveillance, Epidemiology, End Results (SEER) analysis. J Surg Oncol. 2018;117(4):644–650. doi:10.1002/jso.24908
   PubMed Web of Science ®Google Scholar
• Park S, Choi S, Cho YA, et al. Evaluation of the American Joint Committee on Cancer (AJCC) 8th edition staging system for hepatocellular carcinoma in 1008 patients with curative resection. Cancer Res Treat. 2020;52(4):1145–1152. doi:10.4143/crt.2020.208
   PubMed Web of Science ®Google Scholar
• Liao R, Wei XF, Che P, Yin KL, Liu L. Nomograms incorporating the CNLC staging system predict the outcome of hepatocellular carcinoma after curative resection. Front Oncol. 2021;11:755920. doi:10.3389/fonc.2021.755920
   PubMed Web of Science ®Google Scholar
• Otto G, Pitton MB, Hoppe-Lotichius M, Weinmann A. Liver transplantation and BCLC classification: limitations impede optimum treatment. Hepatobiliary Pancreat Dis Int. 2021;20(1):6–12. doi:10.1016/j.hbpd.2020.12.009
   PubMed Web of Science ®Google Scholar
• Zhou J, Sun HC, Wang Z, et al. Guidelines for diagnosis and treatment of primary liver cancer in China (2017 edition). Liver Cancer. 2018;7(3):235–260. doi:10.1159/000488035
   PubMed Web of Science ®Google Scholar
• Vitale A, Farinati F, Finotti M, et al. Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications. Cancers. 2021;13(7):1673. doi:10.3390/cancers13071673
   PubMed Web of Science ®Google Scholar
• Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-The ALBI grade. J Clin Oncol. 2015;33(6):550–558. doi:10.1200/JCO.2014.57.9151
   PubMed Web of Science ®Google Scholar
• Wu Y, Tu C, Shao C. Inflammatory indexes in preoperative blood routine to predict early recurrence of hepatocellular carcinoma after curative hepatectomy. BMC Surg. 2021;21(1):178. doi:10.1186/s12893-021-01180-9
   PubMed Web of Science ®Google Scholar
• Wang D, Hu X, Xiao L, et al. Prognostic nutritional index and systemic immune-inflammation index predict the prognosis of patients with HCC. J Gastrointest Surg. 2020;25(2):421–427. doi:10.1007/s11605-019-04492-7
   PubMed Web of Science ®Google Scholar
• Qi Q, Zhuang L, Shen Y, et al. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy. Cancer. 2016;122(14):2158–2167. doi:10.1002/cncr.30057
   PubMed Web of Science ®Google Scholar
• Marcoulides KM, Raykov T. Evaluation of variance inflation factors in regression models using latent variable modeling methods. Educ Psychol Meas. 2019;79(5):874–882. doi:10.1177/0013164418817803
   PubMed Web of Science ®Google Scholar
• Liao Y, Yin G, Fan X. The Positive lymph node ratio predicts survival in T1-4N1-3M0 non-small cell lung cancer: a nomogram using the SEER database. Front Oncol. 2020;10:1356. doi:10.3389/fonc.2020.01356
   PubMed Web of Science ®Google Scholar
• Zheng Z, Guan R, Jianxi W, et al. Microvascular invasion in hepatocellular carcinoma: a review of its definition, clinical significance, and comprehensive management. J Oncol. 2022;2022:9567041. doi:10.1155/2022/9567041
   PubMedGoogle Scholar
• Zou Y, Chen Z, Lou Q, et al. A novel blood index-based model to predict Hepatitis B virus-associated hepatocellular carcinoma recurrence after curative hepatectomy: guidance on adjuvant transcatheter arterial chemoembolization choice. Front Oncol. 2021;11:755235. doi:10.3389/fonc.2021.755235
   PubMed Web of Science ®Google Scholar
• Li SH, Guo ZX, Xiao CZ, et al. Risk factors for early and late intrahepatic recurrence in patients with single hepatocellular carcinoma without macrovascular invasion after curative resection. Asian Pac J Cancer Prev. 2013;14(8):4759–4763. doi:10.7314/APJCP.2013.14.8.4759
   PubMedGoogle Scholar
• Xu B, Chen Z, Zhang J, et al. Prognostic value of peripheral whole blood cell counts derived indexes in gallbladder carcinoma: a systematic review and meta-analysis. Front Oncol. 2021;11:707742. doi:10.3389/fonc.2021.707742
   PubMed Web of Science ®Google Scholar
• Jiang S, Wang S, Wang Q, et al. Systemic Inflammation Response Index (SIRI) independently predicts survival in advanced lung adenocarcinoma patients treated with first-generation EGFR-TKIs. Cancer Manag Res. 2021;13:1315–1322. doi:10.2147/CMAR.S287897
   PubMed Web of Science ®Google Scholar
• Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009;30(7):1073–1081. doi:10.1093/carcin/bgp127
   PubMed Web of Science ®Google Scholar
• Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):e493–e503. doi:10.1016/S1470-2045(14)70263-3
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–444. doi:10.1038/nature07205
   PubMed Web of Science ®Google Scholar
• Maeda H, Akaike T. Nitric oxide and oxygen radicals in infection, inflammation, and cancer. Biochemistry. 1998;63(7):854–865.
   PubMed Web of Science ®Google Scholar
• Digifico E, Balinzo S, Belgiovine C. The dark side of the force: when the immune system is the fuel of tumor onset. Int J Mol Sci. 2021;22(3):1224. doi:10.3390/ijms22031224
   PubMed Web of Science ®Google Scholar
• Qian BZ. Inflammation fires up cancer metastasis. Semin Cancer Biol. 2017;47:170–176. doi:10.1016/j.semcancer.2017.08.006
   PubMed Web of Science ®Google Scholar
• Rawat K, Syeda S, Shrivastava A. Neutrophil-derived granule cargoes: paving the way for tumor growth and progression. Cancer Metastasis Rev. 2021;40(1):221–244. doi:10.1007/s10555-020-09951-1
   PubMed Web of Science ®Google Scholar
• Klein S, Mauch C, Brinker K, et al. Tumor infiltrating lymphocyte clusters are associated with response to immune checkpoint inhibition in BRAF V600(E/K) mutated malignant melanomas. Sci Rep. 2021;11(1):1834. doi:10.1038/s41598-021-81330-4
   PubMed Web of Science ®Google Scholar
• Xie D, Marks R, Zhang M, et al. Nomograms predict overall survival for patients with small-cell lung cancer incorporating pretreatment peripheral blood markers. J Thorac Oncol. 2015;10(8):1213–1220. doi:10.1097/JTO.0000000000000585
   PubMed Web of Science ®Google Scholar
• Kim EY, Song KY. The preoperative and the postoperative neutrophil-to-lymphocyte ratios both predict prognosis in gastric cancer patients. World J Surg Oncol. 2020;18(1):293. doi:10.1186/s12957-020-02059-4
   PubMed Web of Science ®Google Scholar
• Sun L, Jin Y, Hu W, et al. The impacts of systemic immune-inflammation index on clinical outcomes in gallbladder carcinoma. Front Oncol. 2020;10:554521. doi:10.3389/fonc.2020.554521
   PubMed Web of Science ®Google Scholar
• Naggara O, Raymond J, Guilbert F, Roy D, Weill A, Altman DG. Analysis by categorizing or dichotomizing continuous variables is inadvisable: an example from the natural history of unruptured aneurysms. AJNR Am J Neuroradiol. 2011;32(3):437–440. doi:10.3174/ajnr.A2425
   PubMed Web of Science ®Google Scholar
• Royston P, Altman DG, Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med. 2006;25(1):127–141. doi:10.1002/sim.2331
   PubMed Web of Science ®Google Scholar
• Shi X, Li F, Xu Y, Nyalali AMK, Li F. The prognostic value of the preoperative inflammatory index on the survival of glioblastoma patients. Neurol Sci. 2022;43(9):5523–5531. doi:10.1007/s10072-022-06158-w
   PubMed Web of Science ®Google Scholar
• Liu L, Wang W, Zhang Y, et al. Declined preoperative aspartate aminotransferase to neutrophil ratio index predicts poor prognosis in patients with intrahepatic cholangiocarcinoma after hepatectomy. Cancer Res Treat. 2018;50(2):538–550. doi:10.4143/crt.2017.106
   PubMed Web of Science ®Google Scholar